China’s new rules for investigator-initiated trials have sharply curtailed approvals since taking effect in May, according to investigators running ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results